Objectives: Intracranial infections due to multidrug- resistant (MDR) gram-negative pathogens are associated with increased morbidity and mortality. As therapeutic options are limited and systemic drug penetration into the infection focus is difficult, intraventricular therapy has been described. Methods: We report on a patient with intracranial abscess caused by MDR Acinetobacter baumannii. Results: He was treated with high doses of intravenous and intraventricular colistin resulting in microbiological clearance and clinical cure. Therapy was controlled by therapeutic drug monitoring (TDM) of serum and liquor colistin levels. About 100 cases with intraventricular or intrathecal colistin are reported in literature but data on TDM are sparse...
Acinetobacter baumannii (AB) nosocomial infections, especially those due to multi-drug resistant (MD...
Abstract Intraventricular colistin, administered as colistin methanesulfonate (CMS), is the last re...
BACKGROUND: Colistin is uncommonly used in clinical practice; however, the emergence of multidrug-re...
Reports on the safety and efficacy of intraventricularly administered (IVT) colistin for the treatme...
Background: We report a case of a male patient in our hospital who developed associated multidrug-re...
Central nervous system infections caused by Gram-negative bacteria susceptible only to colistin are ...
: The aim of this study was to report the clinical experience of intraventricular colistin for the t...
Management of multidrug-resistant Acinetobacter baumannii (MDRAB) meningitis/ventriculitis is a diff...
Central nervous system (CNS) infections constitute a life-threatening condition, especially in child...
Colistin pharmacokinetics were prospectively studied after intravenous administration of colistin me...
Multidrug-resistant (MDR) bacterial infections are increasing in Taiwan hospitals, prompting the com...
This paper reports on a 71-year-old Caucasian male who underwent neurosurgery for an oligodendrogli...
This paper reports on a 71- year-old Caucasian male who underwent neurosurgery for an oligodendrogli...
AbstractTreatment limitations exist for drug-resistant Acinetobacter baumannii central nervous syste...
Introduction: Post-neurosurgical nosocomial meningitis has become an important subgroup of bacterial...
Acinetobacter baumannii (AB) nosocomial infections, especially those due to multi-drug resistant (MD...
Abstract Intraventricular colistin, administered as colistin methanesulfonate (CMS), is the last re...
BACKGROUND: Colistin is uncommonly used in clinical practice; however, the emergence of multidrug-re...
Reports on the safety and efficacy of intraventricularly administered (IVT) colistin for the treatme...
Background: We report a case of a male patient in our hospital who developed associated multidrug-re...
Central nervous system infections caused by Gram-negative bacteria susceptible only to colistin are ...
: The aim of this study was to report the clinical experience of intraventricular colistin for the t...
Management of multidrug-resistant Acinetobacter baumannii (MDRAB) meningitis/ventriculitis is a diff...
Central nervous system (CNS) infections constitute a life-threatening condition, especially in child...
Colistin pharmacokinetics were prospectively studied after intravenous administration of colistin me...
Multidrug-resistant (MDR) bacterial infections are increasing in Taiwan hospitals, prompting the com...
This paper reports on a 71-year-old Caucasian male who underwent neurosurgery for an oligodendrogli...
This paper reports on a 71- year-old Caucasian male who underwent neurosurgery for an oligodendrogli...
AbstractTreatment limitations exist for drug-resistant Acinetobacter baumannii central nervous syste...
Introduction: Post-neurosurgical nosocomial meningitis has become an important subgroup of bacterial...
Acinetobacter baumannii (AB) nosocomial infections, especially those due to multi-drug resistant (MD...
Abstract Intraventricular colistin, administered as colistin methanesulfonate (CMS), is the last re...
BACKGROUND: Colistin is uncommonly used in clinical practice; however, the emergence of multidrug-re...